home All News open_in_new Full Article

CORRECTING and REPLACING: Gunze Medical and HistoSonics Enter into Exclusive Distributor Agreement in Japan for Noninvasive Platform and Proprietary Sonic Beam Therapy Using Histotripsy Technology

OSAKA, Japan — Gunze Limited (Headquarters: Osaka, Japan; President: Toshiyasu Saguchi) [TOKYO:3002] is pleased to announce that its wholly owned subsidiary, Gunze Medical Limited (Headquarters: Osaka, Japan; President: Shojiro Matsuda) and HistoSonics, Inc. (Headquarters: Minneapolis, MN USA; CEO: Mike Blue) have entered into an agreement to exclusively distribute a noninvasive platform and proprietary sonic beam […]


today 16 h. ago attach_file Events



ID: 2349316444
Add Watch Country

arrow_drop_down